arginyl-glycyl-aspartic acid and Eye Diseases

arginyl-glycyl-aspartic acid has been researched along with Eye Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheresh, DA; Varner, JA	1

Reviews

1 review(s) available for arginyl-glycyl-aspartic acid and Eye Diseases

Article	Year
Tumor angiogenesis and the role of vascular cell integrin alphavbeta3. Important advances in oncology, 1996 Topics: Adult; Animals; Antineoplastic Agents; Apoptosis; Cell Adhesion Molecules; Cell Transformation, Neoplastic; Child; Clinical Trials, Phase II as Topic; Endothelial Growth Factors; Extracellular Matrix Proteins; Eye Diseases; Female; Fibroblast Growth Factors; Humans; Inflammation; Lymphokines; Male; Metalloendopeptidases; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Receptor Protein-Tyrosine Kinases; Receptors, Fibroblast Growth Factor; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Receptors, Vitronectin; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1996

Article

Year

Tumor angiogenesis and the role of vascular cell integrin alphavbeta3.

Important advances in oncology, 1996

Topics: Adult; Animals; Antineoplastic Agents; Apoptosis; Cell Adhesion Molecules; Cell Transformation, Neoplastic; Child; Clinical Trials, Phase II as Topic; Endothelial Growth Factors; Extracellular Matrix Proteins; Eye Diseases; Female; Fibroblast Growth Factors; Humans; Inflammation; Lymphokines; Male; Metalloendopeptidases; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Receptor Protein-Tyrosine Kinases; Receptors, Fibroblast Growth Factor; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Receptors, Vitronectin; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

1996